QualityStocksNewsBreaks Archives - Page 558 of 1452

MondayNov 15, 2021 1:02 pm

QualityStocksNewsBreaks– RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch delivery and monitoring device, software and data platform with Ei.Ventures’ proprietary psychedelic formulations. In addition, the two companies will work together on advancing Ei.Ventures’ research and development strategy. The partnership takes the two companies a step closer to negotiating and finalizing certain definitive research and…

MondayNov 15, 2021 12:34 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Featured in Equity Research Report

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, was featured in a recent equity research report. The coverage, initiated by Maxim Group LLC, highlights MINDCURE’s efforts to set the stage to unlock value for the company. This includes work on its ongoing programs and clinical development, including synthetic ibogaine, for which it is planning a preclinical study with its research partner to initially conduct cardiac and neurological screens with data and potentially move into behavioral studies. In addition, the company plans to schedule a pre-IND meeting for its…

MondayNov 15, 2021 12:31 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Uniquely Positioned in Cancer Screening, Detection Market

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is the company behind a proprietary novel technology for early cancer screening and detection — the Cancer Differentiation Analysis (“CDA”). Powered by a database containing over 200,000 samples and cases, AnPac Bio’s CDA technology can detect and carry multifaceted information, including cellular and protein-level details, to determine the existence of cancerous environments. At present, the company’s CDA platform “can detect up to 26 different types of cancer, which gives AnPac Bio a major advantage over industry peers in terms of cost effectiveness, multi-cancer testing, ability…

MondayNov 15, 2021 12:09 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Committed to Making Psychedelic Wellness Accessible to the Masses

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, is well positioned to capitalize on the psychedelic industry’s continued growth trajectory. “The company owns and operates a self-sustaining ecosystem of businesses in the psychedelic space consisting of media, science and health business verticals. Delic has been particularly active on the mergers and acquisitions front over the last several months in a bid to further broaden the company’s business horizons,” reads a recent article. In March, the company acquired the brand and IP of Homestead, a legacy counterculture distributor of psychedelic media and creator of one of the first…

MondayNov 15, 2021 11:57 am

QualityStocksNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Empowering Clients to Make Better Decisions Through Actionable Predictive Insight

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is emerging as a leader in the AI world. Recently, Harvard Business Review (“HBR”) reported that AI could be instrumental, when combined with analytics, in alleviating skill shortages by creating solutions and augmenting support activities, as well as boosting productivity, delivering new products and services, and addressing supply chain issues. The HBR report predicts that the coming boom in business growth and innovation will be a data-driven one. “Next-generation technologies — artificial intelligence and analytics — will play a key role in boosting business…

MondayNov 15, 2021 11:30 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Completes Purchase of Tunica, Mississippi, EV Assembly Plant

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has closed on the purchase of an EV assembly plant located in Tunica, Mississippi. Mullen has purchased the Advanced Manufacturing and Engineering Center (“AMEC”) without any debt and now will focus on hiring the skilled trades and support staff needed to start initial preproduction class 1 and class 2 EV Cargo Vans. The purchase of AMEC is tied to the company’s previously announced plans to add another 1.2 million square feet of manufacturing space to the facility; the additional space will be designed to support class 1 and class 2…

MondayNov 15, 2021 11:26 am

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Plans to Develop Next-Generation Hearing Products Following Acquisition

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently acquired all assets and operations of iHEAR Medical Inc., a venture-backed pioneer in online direct-to-consumer hearing solutions. INND expects the acquisition to expand and solidify its position as the emerging leader in the market of direct-to-consumer and over-the-counter hearing products. In addition, the acquisition offers InnerScope access to over 40 patents in hearing technology, brings world-class innovation and helps the company broaden its product offering. iHEAR, which has demonstrated a track record of bringing novel hearing solutions to the market, boasts a…

MondayNov 15, 2021 11:02 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q2 Financial Results, Business Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has released its unaudited second-quarter results and announced a conference call to review the report. The report covers the period ended Sept. 30, 2021. Highlights in the report included the company’s announcement of preclinical data for its novel deuterated psilocybin analog, CYB003, for the potential treatment of major depressive disorder and alcohol use disorder. The company has also been granted a Schedule I manufacturing license from the U.S. Drug Enforcement Agency for its Boston-area research lab and has received FDA approval to proceed with a company-sponsored…

MondayNov 15, 2021 10:04 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Q4 Virtual Investor Summit

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”), will be presenting at the upcoming Q4 Virtual Investor Summit. The summit is scheduled for Nov. 17, 2021. Vivos CEO Kirk Huntsman, chief financial officer Brad Amman, and investor relations officer Ed Loew will provide key information about the company during a life webcast slated to begin at 11:45 a.m. EST. To view the full presentation, visit https://ibn.fm/NRKmq To view the full press release, visit https://ibn.fm/ioAfi About Vivos Therapeutics Inc. Vivos Therapeutics is a medical technology company focused…

FridayNov 12, 2021 3:08 pm

QualityStocksNewsBreaks – Mind Cure Health Inc.’s (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) iSTRYM Opening New Revenue Source, Helping Fuel Further Growth, Expansion

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently signed a non-binding letter of intent (“LOI”) with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF), a biotech company with clinical operations researching, developing and delivering psychedelic medicine to treat addiction. “Under the LOI, MINDCURE becomes a distributor of Awakn’s ketamine-assisted psychotherapy for alcohol use disorder in the United States and Canada, through its proprietary digital therapeutics platform, iSTRYM,” reads a recent article. In addition to distributing its partners’ protocols, MINDCURE will also be distributing its own protocols through iSTRYM.…

Site Search

Company Search

Category: QualityStocksNewsBreaks